FRST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FRST is a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a constructive technical setup, improving fundamentals, and a fresh bullish analyst initiation that suggests meaningful upside from the current pre-market price of 14.66. I would buy it now rather than wait for a perfect entry, since the setup is already aligned with a long-term accumulation thesis.
Technically, FRST is in a bullish trend. The moving averages are aligned positively with SMA_5 > SMA_20 > SMA_200, which supports an established uptrend. MACD histogram is positive at 0.0658, though it is contracting, so momentum is still positive but not accelerating. RSI_6 at 67.55 is near overbought but not extreme, meaning the stock is extended yet not at a clear reversal level. Key levels to watch are pivot 14.36, resistance at 14.807 and 15.083, and support at 13.913 and 13.637. Overall, the price structure favors continued strength more than deterioration.
["Keefe Bruyette initiated coverage with an Outperform rating and $17 price target, implying about 23% upside from the current price.", "Analyst commentary says the business is at an 'inflection point' and that prior credit headwinds and one-off expenses are now behind it.", "Q1 2026 showed revenue growth of 32.75% YoY to $29.622 million.", "Net interest margin improved to 3.43%, which is a strong banking profitability signal.", "The company reported a Q1 2026 profit of $7.3 million and declared a quarterly dividend of $0.10 per share.", "Options positioning is strongly bullish with extremely low put activity.", "Moving averages and MACD remain supportive of the current uptrend."]
["Net income fell 67.70% YoY in Q1 2026, which means profitability has not fully normalized yet.", "EPS dropped 67.39% YoY, showing earnings remain pressured versus the prior year.", "RSI is near the upper end of its range, so short-term upside may be somewhat stretched.", "No notable hedge fund accumulation trend was reported.", "No notable insider buying trend was reported.", "No recent congress trading data was available.", "Pattern-based estimates suggest weak near-term performance over the next month."]
In Q1 2026, Primis Financial showed a mixed but improving earnings picture. Revenue increased 32.75% year over year to $29.622 million, which is a strong growth trend. The company also posted a $7.3 million profit, operating EPS of $0.33, and a net interest margin of 3.43%, all of which point to improving core banking performance. However, net income and EPS were both down sharply year over year, indicating that the latest quarter still reflects some earnings pressure despite the revenue and margin improvement.
Recent analyst sentiment is bullish. Keefe Bruyette initiated coverage on 2026-04-20 with an Outperform rating and a $17 target, calling Primis an inflection point and expecting roughly 23% upside. This is a meaningful positive change because it frames the recent weakness as temporary and supports a buy thesis. The pros view is that the bank’s fundamentals are improving and the stock still offers upside. The cons view is that earnings remain down sharply year over year, so the recovery is still incomplete.
